Membrane-active peptides for non-viral gene therapy: making the safest easier

Trends in Biotechnology

Volumn 26, Issue 5, 2008, Pages 267-275

  Ferrer Miralles, Neus ^a,b   Vázquez, Esther ^a,b   Villaverde, Antonio ^a,b  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b BIOMATERIALES Y NANOMEDICINA CIBER BBN   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

GENE EXPRESSION; GENE TRANSFER; NUCLEIC ACIDS;

NATURAL SOURCES; TRANSGENE EXPRESSION LEVELS;

PEPTIDES;

ANTISENSE OLIGONUCLEOTIDE; LIPID; LIPOSOME; NANOPARTICLE; NUCLEIC ACID; PEPTIDE; POLYMER; VIRUS PROTEIN;

AMINO TERMINAL SEQUENCE; CELL TYPE; ENDOCYTOSIS; GENE DELIVERY SYSTEM; GENE TARGETING; GENE THERAPY; GENE TRANSFER; HUMAN; MACROMOLECULE; MEMBRANE TRANSPORT; NONHUMAN; NUCLEAR LOCALIZATION SIGNAL; PRIORITY JOURNAL; REVIEW; VIRUS LIKE AGENT;

ANIMALS; BIOLOGICAL TRANSPORT; DNA; GENE THERAPY; GENE TRANSFER TECHNIQUES; HUMANS; INTRACELLULAR MEMBRANES; MODELS, BIOLOGICAL; PEPTIDES;

EID: 42149121346     PISSN: 01677799     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tibtech.2008.02.003     Document Type: Review

References (97)

1. Baum C. Insertional mutagenesis in gene therapy and stem cell biology. Curr. Opin. Hematol. 14 (2007) 337-342
2. Nienhuis A.W., et al. Genotoxicity of retroviral integration in hematopoietic cells. Mol. Ther. 13 (2006) 1031-1049
3. Abbott A. Questions linger about unexplained gene-therapy trial death. Nat. Med. 12 (2006) 597
4. Smaglik P. Merck blocks 'safer' gene therapy trials. Nature 403 (2000) 817
5. Edelstein M.L., et al. Gene therapy clinical trials worldwide to 2007 - an update. J. Gene Med. 9 (2007) 833-842
6. Vassaux G., et al. Bacterial gene therapy strategies. J. Pathol. 208 (2006) 290-298
7. Laner A., et al. Bacterial transfer of large functional genomic DNA into human cells. Gene Ther. 12 (2005) 1559-1572
8. Bachmann A.S., et al. A simple method for the rapid purification of copia virus-like particles from Drosophila Schneider 2 cells. J. Virol. Methods 115 (2004) 159-165
9. De Laporte L., et al. Design of modular non-viral gene therapy vectors. Biomaterials 27 (2006) 947-954
10. Mastrobattista E., et al. Artificial viruses: a nanotechnological approach to gene delivery. Nat. Rev. Drug Discov. 5 (2006) 115-121
11. Wagner E. Strategies to improve DNA polyplexes for in vivo gene transfer: will 'artificial viruses' be the answer?. Pharm. Res. 21 (2004) 8-14
12. Lewinski N., et al. Cytotoxicity of nanoparticles. Small 4 (2008) 26-49
13. Li S.D., and Huang L. Gene therapy progress and prospects: non-viral gene therapy by systemic delivery. Gene Ther. 13 (2006) 1313-1319
14. Aris A., and Villaverde A. Modular protein engineering for non-viral gene therapy. Trends Biotechnol. 22 (2004) 371-377
15. Pante N., and Aebi U. Molecular dissection of the nuclear pore complex. Crit. Rev. Biochem. Mol. Biol. 31 (1996) 153-199
16. Stoffler D., et al. Getting across the nuclear pore complex: new insights into nucleocytoplasmic transport. Can. J. Physiol. Pharmacol. 84 (2006) 499-507
17. Chan C.K., and Jans D.A. Using nuclear targeting signals to enhance non-viral gene transfer. Immunol. Cell Biol. 80 (2002) 119-130
18. Dincer S., et al. Intelligent polymers as nonviral vectors. Gene Ther. 12 Suppl. 1 (2005) S139-S145
19. Ma B., et al. Lipoplex morphologies and their influences on transfection efficiency in gene delivery. J. Control. Release 123 (2007) 184-194
20. Ikegami S., et al. Targeting gene therapy for prostate cancer cells by liposomes complexed with anti-prostate-specific membrane antigen monoclonal antibody. Hum. Gene Ther. 17 (2006) 997-1005
21. Wagner E., et al. Targeting of polyplexes: toward synthetic virus vector systems. Adv. Genet. 53PA (2005) 333-354
22. Rocha A., et al. Improvement of DNA transfection with cationic liposomes. J. Physiol. Biochem. 58 (2002) 45-56
23. Ewert K., et al. Cationic lipid-DNA complexes for gene therapy: understanding the relationship between complex structure and gene delivery pathways at the molecular level. Curr. Med. Chem. 11 (2004) 133-149
24. Roy I., et al. Calcium phosphate nanoparticles as novel non-viral vectors for targeted gene delivery. Int. J. Pharm. 250 (2003) 25-33
25. Manunta M., et al. Gene delivery by dendrimers operates via a cholesterol dependent pathway. Nucleic Acids Res. 32 (2004) 2730-2739
26. Oishi M., et al. Enhanced growth inhibition of hepatic multicellular tumor spheroids by lactosylated poly(ethylene glycol)-siRNA conjugate formulated in PEGylated polyplexes. ChemMedChem 2 (2007) 1290-1297
27. Turk M., et al. Smart and cationic poly(NIPA)/PEI block copolymers as non-viral vectors: in vitro and in vivo transfection studies. J. Tissue Eng. Regen. Med. 1 (2007) 377-388
28. Rozema D.B., et al. Dynamic polyconjugates for targeted in vivo delivery of siRNA to hepatocytes. Proc. Natl. Acad. Sci. U. S. A. 104 (2007) 12982-12987
29. Wolff J.A., and Rozema D.B. Breaking the bonds: non-viral vectors become chemically dynamic. Mol. Ther. 16 (2008) 8-15
30. Ou W.C., et al. The major capsid protein, VP1, of human JC virus expressed in Escherichia coli is able to self-assemble into a capsid-like particle and deliver exogenous DNA into human kidney cells. J. Gen. Virol. 80 (1999) 39-46
31. Mena J.A., et al. Intracellular distribution of rotavirus structural proteins and virus-like particles expressed in the insect cell-baculovirus system. J. Biotechnol. 122 (2006) 443-452
32. Di Martino B., et al. Assembly of feline calicivirus-like particle and its immunogenicity. Vet. Microbiol. 120 (2007) 173-178
33. Bach P., et al. Vesicular stomatitis virus glycoprotein displaying retrovirus-like particles induce a type I IFN receptor-dependent switch to neutralizing IgG antibodies. J. Immunol. 178 (2007) 5839-5847
34. Aris A., et al. Exploiting viral cell-targeting abilities in a single polypeptide, non-infectious, recombinant vehicle for integrin-mediated DNA delivery and gene expression. Biotechnol. Bioeng. 68 (2000) 689-696
35. Box M., et al. A multi-domain protein system based on the HC fragment of tetanus toxin for targeting DNA to neuronal cells. J. Drug Target. 11 (2003) 333-343
36. Aris A., and Villaverde A. Molecular organization of protein-DNA complexes for cell-targeted DNA delivery. Biochem. Biophys. Res. Commun. 278 (2000) 455-461
37. Aris A., and Villaverde A. Engineering nuclear localization signals in modular protein vehicles for gene therapy. Biochem. Biophys. Res. Commun. 304 (2003) 625-631
38. Peluffo H., et al. Neuroprotection from NMDA excitotoxic lesion by Cu/Zn superoxide dismutase gene delivery to the postnatal rat brain by a modular protein vector. BMC Neurosci. 7 (2006) 35
39. Read M.L., et al. Barriers to gene delivery using synthetic vectors. Adv. Genet. 53PA (2005) 19-46
40. Duchardt F., et al. A comprehensive model for the cellular uptake of cationic cell-penetrating peptides. Traffic 8 (2007) 848-866
41. Medina-Kauwe L.K., et al. Intracellular trafficking of nonviral vectors. Gene Ther. 12 (2005) 1734-1751
42. Khalil I.A., et al. Uptake pathways and subsequent intracellular trafficking in nonviral gene delivery. Pharmacol. Rev. 58 (2006) 32-45
43. Schnitzer J.E. Caveolae: from basic trafficking mechanisms to targeting transcytosis for tissue-specific drug and gene delivery in vivo. Adv. Drug Deliv. Rev. 49 (2001) 265-280
44. Wadia J.S., et al. Transducible TAT-HA fusogenic peptide enhances escape of TAT-fusion proteins after lipid raft macropinocytosis. Nat. Med. 10 (2004) 310-315
45. Lechardeur D., et al. Metabolic instability of plasmid DNA in the cytosol: a potential barrier to gene transfer. Gene Ther. 6 (1999) 482-497
46. Richard J.P., et al. Cell-penetrating peptides. A reevaluation of the mechanism of cellular uptake. J. Biol. Chem. 278 (2003) 585-590
47. Astriab-Fisher A., et al. Conjugates of antisense oligonucleotides with the Tat and antennapedia cell-penetrating peptides: effects on cellular uptake, binding to target sequences, and biologic actions. Pharm. Res. 19 (2002) 744-754
48. Eguchi A., et al. Protein transduction domain of HIV-1 Tat protein promotes efficient delivery of DNA into mammalian cells. J. Biol. Chem. 276 (2001) 26204-26210
49. Fittipaldi A., et al. Cell membrane lipid rafts mediate caveolar endocytosis of HIV-1 Tat fusion proteins. J. Biol. Chem. 278 (2003) 34141-34149
50. Vendeville A., et al. HIV-1 Tat enters T cells using coated pits before translocating from acidified endosomes and eliciting biological responses. Mol. Biol. Cell 15 (2004) 2347-2360
51. Rejman J., et al. Size-dependent internalization of particles via the pathways of clathrin- and caveolae-mediated endocytosis. Biochem. J. 377 (2004) 159-169
52. Gupta B., et al. Intracellular delivery of large molecules and small particles by cell-penetrating proteins and peptides. Adv. Drug Deliv. Rev. 57 (2005) 637-651
53. Nishiyama N., et al. Light-induced gene transfer from packaged DNA enveloped in a dendrimeric photosensitizer. Nat. Mater. 4 (2005) 934-941
54. Muller S., et al. TransMabs: cell-penetrating antibodies, the next generation. Expert Opin. Biol. Ther. 5 (2005) 237-241
55. Dietz G.P., and Bahr M. Delivery of bioactive molecules into the cell: the Trojan horse approach. Mol. Cell. Neurosci. 27 (2004) 85-131
56. Pardridge W.M. Blood-brain barrier delivery of protein and non-viral gene therapeutics with molecular Trojan horses. J. Control. Release 122 (2007) 345-348
57. Martin M.E., and Rice K.G. Peptide-guided gene delivery. AAPS J. 9 (2007) E18-E29
58. Henriques, S. T. and. Castanho, M.A (2008) Translocation or membrane disintegration? Implication of peptide-membrane interactions in pep-1 activity. J. Pept. Sci. DOI:10.1002/psc.1003
59. Bechinger B., and Lohner K. Detergent-like actions of linear amphipathic cationic antimicrobial peptides. Biochim. Biophys. Acta 1758 (2006) 1529-1539
60. Huang H.W. Molecular mechanism of antimicrobial peptides: the origin of cooperativity. Biochim. Biophys. Acta 1758 (2006) 1292-1302
61. Rentsendorj A., et al. The Ad5 fiber mediates nonviral gene transfer in the absence of the whole virus, utilizing a novel cell entry pathway. Gene Ther. 12 (2005) 225-237
62. Plank C., et al. The influence of endosome-disruptive peptides on gene transfer using synthetic virus-like gene transfer systems. J. Biol. Chem. 269 (1994) 12918-12924
63. Wagner E. Application of membrane-active peptides for nonviral gene delivery. Adv. Drug Deliv. Rev. 38 (1999) 279-289
64. Youngblood D.S., et al. Stability of cell-penetrating peptide-morpholino oligomer conjugates in human serum and in cells. Bioconjug. Chem. 18 (2007) 50-60
65. Lundberg P., et al. Delivery of short interfering RNA using endosomolytic cell-penetrating peptides. FASEB J. 21 (2007) 2664-2671
66. Kichler A., et al. Characterization of the gene transfer process mediated by histidine-rich peptides. J. Mol. Med. 85 (2007) 191-201
67. Shiraishi T., and Nielsen P.E. Enhanced delivery of cell-penetrating peptide-peptide nucleic acid conjugates by endosomal disruption. Nat. Protoc. 1 (2006) 633-636
68. Ogris M., et al. Melittin enables efficient vesicular escape and enhanced nuclear access of nonviral gene delivery vectors. J. Biol. Chem. 276 (2001) 47550-47555
69. Malboeuf C.M., et al. Human papillomavirus-like particles mediate functional delivery of plasmid DNA to antigen presenting cells in vivo. Vaccine 25 (2007) 3270-3276
70. Lundberg P., and Langel U. A brief introduction to cell-penetrating peptides. J. Mol. Recognit. 16 (2003) 227-233
71. Henriques S.T., et al. Cell-penetrating peptides and antimicrobial peptides: how different are they?. Biochem. J. 399 (2006) 1-7
72. Piersanti S., et al. Mammalian cell transduction and internalization properties of lambda phages displaying the full-length adenoviral penton base or its central domain. J. Mol. Med. 82 (2004) 467-476
73. Zauner W., et al. Rhinovirus-mediated endosomal release of transfection complexes. J. Virol. 69 (1995) 1085-1092
74. Rudolph C., et al. Oligomers of the arginine-rich motif of the HIV-1 TAT protein are capable of transferring plasmid DNA into cells. J. Biol. Chem. 278 (2003) 11411-11418
75. Chiu Y.L., et al. Visualizing a correlation between siRNA localization, cellular uptake, and RNAi in living cells. Chem. Biol. 11 (2004) 1165-1175
76. Baru M., et al. Lysosome-disrupting peptide increases the efficiency of in vivo gene transfer by liposome-encapsulated DNA. J. Drug Target. 6 (1998) 191-199
77. van Rossenberg S.M., et al. Targeted lysosome disruptive elements for improvement of parenchymal liver cell-specific gene delivery. J. Biol. Chem. 277 (2002) 45803-45810
78. Kichler A., et al. Influence of membrane-active peptides on lipospermine/DNA complex mediated gene transfer. Bioconjug. Chem. 8 (1997) 213-221
79. Schuster M.J., et al. Multicomponent DNA carrier with a vesicular stomatitis virus G-peptide greatly enhances liver-targeted gene expression in mice. Bioconjug. Chem. 10 (1999) 1075-1083
80. Saito G., et al. Enhanced cytosolic delivery of plasmid DNA by a sulfhydryl-activatable listeriolysin O/protamine conjugate utilizing cellular reducing potential. Gene Ther. 10 (2003) 72-83
81. Fominaya J., and Wels W. Target cell-specific DNA transfer mediated by a chimeric multidomain protein. Novel non-viral gene delivery system. J. Biol. Chem. 271 (1996) 10560-10568
82. Chen C.P., et al. Gene transfer with poly-melittin peptides. Bioconjug. Chem. 17 (2006) 1057-1062
83. Davidson T.J., et al. Highly efficient small interfering RNA delivery to primary mammalian neurons induces MicroRNA-like effects before mRNA degradation. J. Neurosci. 24 (2004) 10040-10046
84. Wyman T.B., et al. Design, synthesis, and characterization of a cationic peptide that binds to nucleic acids and permeabilizes bilayers. Biochemistry 36 (1997) 3008-3017
85. McKenzie D.L., et al. Low molecular weight disulfide cross-linking peptides as nonviral gene delivery carriers. Bioconjug. Chem. 11 (2000) 901-909
86. Midoux P., et al. Membrane permeabilization and efficient gene transfer by a peptide containing several histidines. Bioconjug. Chem. 9 (1998) 260-267
87. Unnamalai N., et al. Cationic oligopeptide-mediated delivery of dsRNA for post-transcriptional gene silencing in plant cells. FEBS Lett. 566 (2004) 307-310
88. Kumar P., et al. Transvascular delivery of small interfering RNA to the central nervous system. Nature 448 (2007) 39-43
89. Simeoni F., et al. Insight into the mechanism of the peptide-based gene delivery system MPG: implications for delivery of siRNA into mammalian cells. Nucleic Acids Res. 31 (2003) 2717-2724
90. Gottschalk S., et al. A novel DNA-peptide complex for efficient gene transfer and expression in mammalian cells. Gene Ther. 3 (1996) 448-457
91. Rittner K., et al. New basic membrane-destabilizing peptides for plasmid-based gene delivery in vitro and in vivo. Mol. Ther. 5 (2002) 104-114
92. Muratovska A., and Eccles M.R. Conjugate for efficient delivery of short interfering RNA (siRNA) into mammalian cells. FEBS Lett. 558 (2004) 63-68
93. El-Andaloussi S., et al. TP10, a delivery vector for decoy oligonucleotides targeting the Myc protein. J. Control. Release 110 (2005) 189-201
94. Suntoke T.R., and Chan D.C. The fusion activity of HIV-1 gp41 depends on interhelical interactions. J. Biol. Chem. 280 (2005) 19852-19857
95. Heinz F.X., et al. The entry machinery of flaviviruses. In: Calisher C.H., and Griffin D.E. (Eds). Archives of Virology, Supplement 18: Emergence and Control of Zoonotic Viral Encephalitides (2004), Springer 133-137
96. Di Trani L., et al. Different pH requirements are associated with divergent inhibitory effects of chloroquine on human and avian influenza A viruses. Virol. J. 4 (2007) 39
97. Wiethoff C.M., et al. Adenovirus protein VI mediates membrane disruption following capsid disassembly. J. Virol. 79 (2005) 1992-2000